[Retracted] Effects of Xuefu Zhuyu Granules on Patients with Stable Coronary Heart Disease: A Double-Blind, Randomized, and Placebo-Controlled Study

Table 3

The safety endpoints of stable CHD patients receiving Xuefu Zhuyu granules or placebo after 12 weeks.

	Placebo group			Xuefu Zhuyu group			value
	Baseline ()	12 weeks ()	value	Baseline ()	12 weeks ()	value
Vital signs
Temperature (°C)			0.025			0.323	0.701
Breath			0.134			0.530	0.721
Pulse rate			0.439			0.274	0.471
Heart rate (bpm)			0.599			0.698	0.379
Systolic BP (mmHg)			0.112			0.083	0.580
Diastolic BP (mmHg)			0.021			0.035	0.950
Abnormal blood routine (%)	10.5	17.6	0.655	25	30	0.705	0.462
Abnormal urine routine (%)	42.1	41.2	1.000	35	44.4	0.414	1.000
Abnormal stool routine (%)	7.1	12.5	1.000	0	0	1.000	0.400
Abnormal liver function (%)	10.5	5.9	0.564	5	10	0.564	1.000
Abnormal kidney function (%)	0	0	1.000	5	10	0.317	0.489
Bleeding point (%)	0	0		0	0
Ecchymosis (%)	0	0		0	0
Serious adverse events
Death	0	0		0	0
Hospitalization	0	0		0	0
Worsening CHD	0	0		0	0
Stroke	0	0		0	0
Unknown reason	0	0		0	0